• Pifithrin-α: Precision p53 Inhibitor for Ferroptosis Researc

  2026-07-20

  Pifithrin-α (PFTα) empowers researchers to dissect and modulate p53-dependent apoptosis and ferroptosis pathways, with clear advantages for neurotoxicity, cancer therapy side effect mitigation, and stem cell biology. This article translates advanced experimental insights—including from maternal deltamethrin neurotoxicity studies—into actionable protocols, troubleshooting tips, and workflow optimizations for high-impact p53 pathway research.

• KU-60019: Advanced ATM Kinase Inhibitor for Glioma Research

  2026-07-20

  KU-60019 offers unmatched potency and selectivity as an ATM kinase inhibitor, empowering researchers to dissect DNA damage response pathways and optimize radiosensitization in glioma models. Explore how this tool unlocks reproducible workflows, robust migration/invasion assays, and troubleshooting strategies, all supported by APExBIO’s rigorous standards.

• CORE LNPs Enable Spleen-Targeted mRNA Delivery via Cholester

  2026-07-19

  The referenced study introduces CORE LNPs, a new class of lipid nanoparticles incorporating structurally modified cholesterol to shift mRNA expression from the liver to the spleen following systemic administration. This innovation advances the field by enabling organ-selective delivery, with implications for immunotherapy and vaccine development.

• Humanized Gs-coupled DREADD: Advancing Neural Circuit Modula

  2026-07-18

  This study introduces a fully humanized Gs-coupled DREADD (hM3Ds), addressing immunogenicity concerns for translational neuroscience. The humanized receptor demonstrates effective neuronal activation and behavioral rescue in Parkinsonian mouse models, paving the way for safer chemogenetic tools in both research and potential clinical settings.

• Vitamin D/VDR Drives Endometrial Decidualization via Estroge

  2026-07-17

  This study demonstrates that vitamin D, through its receptor VDR, directly enhances endometrial stromal cell decidualization by upregulating estrogen synthesis and key decidualization markers. These findings provide mechanistic insight into how vitamin D status influences endometrial receptivity, informing future infertility and hormone replacement therapy research.

• 10058-F4: c-Myc-Max Dimerization Inhibitor in Cancer Researc

  2026-07-17

  The 10058-F4 c-Myc-Max dimerization inhibitor from APExBIO empowers researchers to disrupt oncogenic transcription and dissect mitochondrial apoptosis in AML and prostate cancer models. This article details actionable protocols, troubleshooting strategies, and practical integration of recent breakthroughs in telomerase regulation.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Advancing Sumoylation In

  2026-07-16

  2-D08 (2’,3’,4’-trihydroxyflavone) enables precise, selective inhibition of protein sumoylation in cancer and mitochondrial research, outperforming traditional tools in mechanistic clarity and assay compatibility. Its unique workflow advantages empower researchers to dissect posttranslational pathways with high specificity, as demonstrated in cutting-edge studies targeting mitophagy and disease models.

• BIIE 0246: Decoding Y2R Antagonism for Adipose-Neural Axis R

  2026-07-16

  Explore how BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, enables advanced dissection of adipose-neural interactions in cardiac and metabolic models. This article provides unique methodological insights and practical guidance for leveraging BIIE 0246 in translational research.

• AMG 487 and the CXCL10-CXCR3 Axis: Precision Tools for Macro

  2026-07-15

  Explore how AMG 487, a potent CXCR3 antagonist, enables precise modulation of macrophage polarization via the CXCL10-CXCR3 axis. This article offers a comprehensive and practical analysis of mechanistic findings and advanced applications, extending beyond current content for researchers in inflammation and immune regulation.

• IGF2BP1-m6A-TUBB4B Axis in Hepatic Stellate Cell Activation

  2026-07-15

  This study demonstrates that the m6A reader IGF2BP1 promotes the activation of hepatic stellate cells (HSCs) by stabilizing TUBB4B mRNA in an m6A-dependent manner, thereby driving liver fibrosis. Targeting the IGF2BP1/TUBB4B/FAK axis reveals new opportunities for antifibrotic research and therapeutic intervention.

• Purmorphamine: Precision Smoothened Agonism in Translational

  2026-07-14

  This thought-leadership article unpacks the mechanistic, experimental, and translational significance of Purmorphamine as a Smoothened agonist. Integrating new evidence from insect sensory biology with established roles in vertebrate bone and neural regeneration, it provides actionable guidance for researchers seeking robust, reproducible Hedgehog pathway modulation. Strategic insights position Purmorphamine as a cornerstone compound for both established and emerging domains, while anchoring the discussion in the latest literature and protocol best practices.

• Tp47 Drives Macrophage Senescence via PKM2-Mediated Metaboli

  2026-07-14

  The reference study uncovers how Treponema pallidum protein Tp47 induces inflammatory senescence in macrophages by modulating PKM2-dependent metabolic pathways. These findings highlight a novel pathogen-immune interaction and open avenues for targeted anti-syphilis strategies and refined cellular senescence assays.

• ML365 Attenuates Postoperative Cognitive Impairment via NLRP

  2026-07-13

  This study demonstrates that ML365, a selective inhibitor of two-pore domain potassium channels, significantly mitigates postoperative cognitive dysfunction (POCD) in aged mice by suppressing NLRP3 inflammasome activation in the hippocampus. The results clarify the mechanistic link between TASK1 channel inhibition, neuroinflammation, and cognitive outcomes, with potential implications for targeted interventions in age-related cognitive decline.

• Lactate-GPR81-FARP1-Rac1 Axis Enables Insulin-Independent Gl

  2026-07-13

  The reference study establishes L-lactate as a key insulin-independent regulator of glucose uptake via activation of the GPR81/FARP1/Rac1 signaling axis in skeletal muscle. This work clarifies how exercise-induced lactate production enhances glucose homeostasis, highlighting new directions for metabolic disease treatment beyond insulin signaling.

• Rotigotine: Dopamine D2/D3 Receptor Agonist in PD Research

  2026-07-12

  Rotigotine is a validated dopamine D2/D3 receptor agonist with proven neuroprotective, antiparkinsonian, and antioxidant activity. This guide translates bench research into actionable workflows—highlighting protocol parameters, troubleshooting, and practical insights for maximizing Rotigotine’s potential in Parkinson’s disease and dopaminergic pathway studies.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page